Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Type 2 Diabetes Mellitus: Synopsis of the Department of Veterans Affairs and Department of Defense Clinical Practice Guideline.

Mayo Clinic proceedings·2024
Same author

Safety and Efficacy of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Veterans With Type 2 Diabetes.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2023
Same author

The Clinical Pharmacy Specialists' Role in Antihypertensive Management Surrounding Bariatric Surgery in a Veterans Affairs Population.

Journal of pharmacy practice·2021
Same author

Are thiazolidinediones a preferred drug treatment for type 2 diabetes?

Expert opinion on pharmacotherapy·2020
Same author

Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes.

Expert opinion on pharmacotherapy·2018
Same author

Pharmacokinetic drug evaluation of extended release lorcaserin for the treatment of obesity.

Expert opinion on drug metabolism & toxicology·2017

Related Experiment Video

Updated: Jun 6, 2026

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health
08:36

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health

Published on: October 9, 2017

Probable interaction between warfarin and bee pollen.

Kathryn M Hurren1, Carrie L Lewis

  • 1Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA. k.hurren@wayne.edu

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

A patient taking warfarin experienced elevated International Normalized Ratio (INR) levels after consuming bee pollen. This probable interaction highlights the need for caution when combining warfarin with herbal supplements like bee pollen.

More Related Videos

Assessing Agrochemical Risk to Mated Honey Bee Queens
08:49

Assessing Agrochemical Risk to Mated Honey Bee Queens

Published on: March 3, 2021

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors
08:50

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors

Published on: July 16, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health
08:36

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health

Published on: October 9, 2017

Assessing Agrochemical Risk to Mated Honey Bee Queens
08:49

Assessing Agrochemical Risk to Mated Honey Bee Queens

Published on: March 3, 2021

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors
08:50

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors

Published on: July 16, 2018

Area of Science:

  • Pharmacology
  • Herbal Medicine Interactions

Background:

  • Warfarin is a common anticoagulant medication used to prevent blood clots.
  • Patients often use herbal products and supplements for perceived health benefits.
  • Potential interactions between warfarin and herbal products require careful monitoring.

Observation:

  • A patient on stable warfarin therapy developed a significantly elevated International Normalized Ratio (INR) of 7.1.
  • The elevated INR occurred after the patient began a regimen of bee pollen granules.
  • No other changes in medication, diet, or health status were reported by the patient.

Findings:

  • Warfarin dosage adjustment was necessary after withholding the medication temporarily.
  • The patient's INR normalized after warfarin was restarted at a reduced dose while continuing bee pollen.
  • A probable interaction between bee pollen and warfarin was indicated by the Drug Interaction Probability Scale.

Implications:

  • Bee pollen consumption may increase the anticoagulant effect of warfarin.
  • Healthcare providers should inquire about herbal supplement use in patients on warfarin.
  • Further research is warranted to elucidate the mechanism of this herb-drug interaction.